Business · 1 sources covering this

Dr Reddy's Shares Slide Over 6% After Semaglutide Batch Quality Concern

Dr Reddys Laboratories shares dropped over 4% after a batch of semaglutide was found out of specification due to an active pharmaceutical ingredient issue.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·1h ago
Dr Reddy's Shares Slide Over 6% After Semaglutide Batch Quality Concern
Dr Reddys Laboratories shares dropped over 4% after a batch of semaglutide was found out of specification due to an active pharmaceutical ingredient issue.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/dfbfdc4798f9efc46ff6068573c3bd8e6562d901"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Dr Reddy's Shares Slide Over 6% After Semaglutide Batch Quality Concern"></iframe>

Dr Reddy's Shares Slide Over 6% After Semaglutide Batch Quality Concern

How 1 sources are covering this

Dr Reddy's Shares Slide Over 6% After Semaglutide Batch Quality Concern

More from Business

Dr. Reddy’s to delay semaglutide supplies due to quality isssue, shares hit

Govt did its part on GCCs, skill up: CEA

Rupee slips 4 paise to 95.52 against U.S. dollar in early trade

Stock markets rebound in early trade after sharp fall in previous session

Reader

Trust & legal

Across the network